|
Volumn 13, Issue 5, 2002, Pages 716-720
|
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase ii study of the italian group for the study of gastrointestinal tract carcinomas (GISCAD)
a b c d e f g h i j k d g d j l c m n n more.. |
Author keywords
Chemotherapy; Colorectal cancer; Oxaliplatin; Raltitrexed
|
Indexed keywords
ANTINEOPLASTIC AGENT;
OXALIPLATIN;
PLATINUM COMPLEX;
QUINAZOLINE DERIVATIVE;
RALTITREXED;
THIOPHENE DERIVATIVE;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONFIDENCE INTERVAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
GASTROINTESTINAL TUMOR;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ITALY;
MALE;
METASTASIS;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL;
TREATMENT OUTCOME;
ADULT;
ANEMIA;
ASTHENIA;
CANCER GROWTH;
CANCER SURVIVAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DIARRHEA;
DRUG EFFICACY;
DRUG INFUSION;
DRUG SAFETY;
DRUG TOLERABILITY;
HEMATOLOGIC DISEASE;
MAJOR CLINICAL STUDY;
NEUROLOGIC DISEASE;
NEUTROPENIA;
PATIENT ATTITUDE;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TIME;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
CONFIDENCE INTERVALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
ITALY;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
ORGANOPLATINUM COMPOUNDS;
PROGNOSIS;
QUINAZOLINES;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
THIOPHENES;
TREATMENT OUTCOME;
HUMAN;
MIDDLE AGE;
|
EID: 0035985287
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf091 Document Type: Article |
Times cited : (58)
|
References (24)
|